[English] 日本語
Yorodumi
- PDB-3h52: Crystal structure of the antagonist form of human glucocorticoid ... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 3h52
TitleCrystal structure of the antagonist form of human glucocorticoid receptor
Components
  • Glucocorticoid receptor
  • Nuclear receptor corepressor 1
KeywordsHORMONE RECEPTOR / PROTEIN-LIGAND COMPLEX / NUCLEAR RECEPTOR / PEPTIDE COMPLEX / HORMONE RECEPTOR 3
Function / homology
Function and homology information


NR1D1 (REV-ERBA) represses gene expression / Loss of MECP2 binding ability to the NCoR/SMRT complex / Regulation of NPAS4 gene transcription / regulation of glucocorticoid biosynthetic process / nuclear glucocorticoid receptor activity / negative regulation of androgen receptor signaling pathway / steroid hormone binding / PTK6 Expression / neuroinflammatory response / glucocorticoid metabolic process ...NR1D1 (REV-ERBA) represses gene expression / Loss of MECP2 binding ability to the NCoR/SMRT complex / Regulation of NPAS4 gene transcription / regulation of glucocorticoid biosynthetic process / nuclear glucocorticoid receptor activity / negative regulation of androgen receptor signaling pathway / steroid hormone binding / PTK6 Expression / neuroinflammatory response / glucocorticoid metabolic process / microglia differentiation / mammary gland duct morphogenesis / maternal behavior / negative regulation of JNK cascade / astrocyte differentiation / negative regulation of glycolytic process / cellular response to glucocorticoid stimulus / motor behavior / nuclear thyroid hormone receptor binding / regulation of gluconeogenesis / adrenal gland development / cellular response to steroid hormone stimulus / negative regulation of fatty acid metabolic process / NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis / Notch-HLH transcription pathway / locomotor rhythm / histone deacetylase complex / Regulation of MECP2 expression and activity / spindle assembly / estrogen response element binding / FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes / nuclear receptor-mediated steroid hormone signaling pathway / core promoter sequence-specific DNA binding / Nuclear signaling by ERBB4 / NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux / cellular response to transforming growth factor beta stimulus / HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand / TBP-class protein binding / transcription repressor complex / steroid binding / Regulation of lipid metabolism by PPARalpha / cellular response to dexamethasone stimulus / negative regulation of miRNA transcription / synaptic transmission, glutamatergic / chromosome segregation / HDACs deacetylate histones / nuclear receptor binding / Downregulation of SMAD2/3:SMAD4 transcriptional activity / RNA polymerase II transcription regulatory region sequence-specific DNA binding / Hsp90 protein binding / Heme signaling / SUMOylation of intracellular receptors / Transcriptional activation of mitochondrial biogenesis / PPARA activates gene expression / Cytoprotection by HMOX1 / NOTCH1 Intracellular Domain Regulates Transcription / mitotic spindle / Constitutive Signaling by NOTCH1 PEST Domain Mutants / Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants / DNA-binding transcription repressor activity, RNA polymerase II-specific / positive regulation of miRNA transcription / histone deacetylase binding / Transcriptional regulation of white adipocyte differentiation / Activation of anterior HOX genes in hindbrain development during early embryogenesis / HCMV Early Events / Nuclear Receptor transcription pathway / spindle / transcription corepressor activity / Regulation of RUNX2 expression and activity / nuclear receptor activity / sequence-specific double-stranded DNA binding / positive regulation of neuron apoptotic process / Circadian Clock / chromatin organization / gene expression / DNA-binding transcription activator activity, RNA polymerase II-specific / RNA polymerase II-specific DNA-binding transcription factor binding / Potential therapeutics for SARS / transcription cis-regulatory region binding / DNA-binding transcription factor activity, RNA polymerase II-specific / nuclear speck / mitochondrial matrix / RNA polymerase II cis-regulatory region sequence-specific DNA binding / DNA-binding transcription factor activity / cell division / negative regulation of DNA-templated transcription / centrosome / apoptotic process / synapse / regulation of DNA-templated transcription / chromatin / regulation of transcription by RNA polymerase II / protein kinase binding / negative regulation of transcription by RNA polymerase II / signal transduction / positive regulation of transcription by RNA polymerase II / protein-containing complex / RNA binding / zinc ion binding / nucleoplasm
Similarity search - Function
Single alpha-helices involved in coiled-coils or other helix-helix interfaces - #340 / N-CoR, GPS2-interacting domain / G-protein pathway suppressor 2-interacting domain / Glucocorticoid receptor / Glucocorticoid receptor / SANT domain profile. / SANT domain / Myb domain / Myb-like DNA-binding domain / SANT SWI3, ADA2, N-CoR and TFIIIB'' DNA-binding domains ...Single alpha-helices involved in coiled-coils or other helix-helix interfaces - #340 / N-CoR, GPS2-interacting domain / G-protein pathway suppressor 2-interacting domain / Glucocorticoid receptor / Glucocorticoid receptor / SANT domain profile. / SANT domain / Myb domain / Myb-like DNA-binding domain / SANT SWI3, ADA2, N-CoR and TFIIIB'' DNA-binding domains / SANT/Myb domain / Single alpha-helices involved in coiled-coils or other helix-helix interfaces / Retinoid X Receptor / Retinoid X Receptor / Helix non-globular / Homeobox-like domain superfamily / Special / Nuclear hormone receptor / Nuclear hormones receptors DNA-binding region signature. / Zinc finger, nuclear hormone receptor-type / Zinc finger, C4 type (two domains) / Nuclear hormone receptors DNA-binding domain profile. / c4 zinc finger in nuclear hormone receptors / Nuclear hormone receptor, ligand-binding domain / Nuclear hormone receptor-like domain superfamily / Ligand-binding domain of nuclear hormone receptor / Nuclear receptor (NR) ligand-binding (LBD) domain profile. / Ligand binding domain of hormone receptors / Zinc finger, NHR/GATA-type / Orthogonal Bundle / Mainly Alpha
Similarity search - Domain/homology
Chem-486 / Nuclear receptor corepressor 1 / Glucocorticoid receptor
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 2.8 Å
AuthorsSchoch, G.A. / Benz, J. / D'Arcy, B. / Stihle, M. / Burger, D. / Thoma, R. / Ruf, A.
CitationJournal: J.Mol.Biol. / Year: 2010
Title: Molecular switch in the glucocorticoid receptor: active and passive antagonist conformations
Authors: Schoch, G.A. / D'Arcy, B. / Stihle, M. / Burger, D. / Bar, D. / Benz, J. / Thoma, R. / Ruf, A.
History
DepositionApr 21, 2009Deposition site: RCSB / Processing site: PDBJ
Revision 1.0Dec 1, 2009Provider: repository / Type: Initial release
Revision 1.1Jul 13, 2011Group: Advisory / Version format compliance
Revision 1.2Feb 5, 2014Group: Database references / Refinement description
Revision 1.3Nov 10, 2021Group: Database references / Derived calculations / Structure summary
Category: chem_comp / database_2 ...chem_comp / database_2 / struct_ref_seq_dif / struct_site
Item: _chem_comp.pdbx_synonyms / _database_2.pdbx_DOI ..._chem_comp.pdbx_synonyms / _database_2.pdbx_DOI / _database_2.pdbx_database_accession / _struct_ref_seq_dif.details / _struct_site.pdbx_auth_asym_id / _struct_site.pdbx_auth_comp_id / _struct_site.pdbx_auth_seq_id
Revision 1.4Nov 1, 2023Group: Data collection / Refinement description
Category: chem_comp_atom / chem_comp_bond / pdbx_initial_refinement_model

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Glucocorticoid receptor
B: Glucocorticoid receptor
C: Glucocorticoid receptor
D: Glucocorticoid receptor
N: Nuclear receptor corepressor 1
M: Nuclear receptor corepressor 1
hetero molecules


Theoretical massNumber of molelcules
Total (without water)123,17611
Polymers121,3656
Non-polymers1,8105
Water48627
1
A: Glucocorticoid receptor
D: Glucocorticoid receptor
N: Nuclear receptor corepressor 1
hetero molecules


Theoretical massNumber of molelcules
Total (without water)61,5425
Polymers60,6833
Non-polymers8592
Water543
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area7660 Å2
ΔGint-52 kcal/mol
Surface area24410 Å2
MethodPISA
2
B: Glucocorticoid receptor
C: Glucocorticoid receptor
M: Nuclear receptor corepressor 1
hetero molecules


Theoretical massNumber of molelcules
Total (without water)61,6346
Polymers60,6833
Non-polymers9513
Water543
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area7550 Å2
ΔGint-47 kcal/mol
Surface area24350 Å2
MethodPISA
Unit cell
Length a, b, c (Å)99.530, 99.530, 252.430
Angle α, β, γ (deg.)90.00, 90.00, 120.00
Int Tables number154
Space group name H-MP3221
DetailsFOUR COPIES OF THE RECEPTOR IN ASU. TWO PAIRS OF HOMODIMERS OF THE RECEPTOR ARE INVOLVED IN A PROPER DOMAIN SWAP INVOLVING THE N-TERMINAL 527-553 AMINO ACIDS. NO EVIDENCE THAT THIS HOMODIMER IS BIOLOGICALLY RELEVANT. THE INTERACTION FORMED BETWEEN RECEPTOR AND NCOR PEPTIDE IS BIOLOGICALLY RELEVANT.

-
Components

#1: Protein
Glucocorticoid receptor / GR / Nuclear receptor subfamily 3 group C member 1


Mass: 29315.096 Da / Num. of mol.: 4 / Fragment: Steroid-binding domain, UNP residues 528-777 / Mutation: F602S,C638D,W712S, E684A, E688A
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Production host: Escherichia coli (E. coli) / References: UniProt: P04150
#2: Protein/peptide Nuclear receptor corepressor 1 / N-CoR1 / N-CoR


Mass: 2052.354 Da / Num. of mol.: 2 / Fragment: CORNR box 3, UNP residues 2258-2276 / Source method: obtained synthetically / Details: synthetic peptide / References: UniProt: O75376
#3: Chemical
ChemComp-486 / 11-(4-DIMETHYLAMINO-PHENYL)-17-HYDROXY-13-METHYL-17-PROP-1-YNYL-1,2,6,7,8,11,12,13,14,15,16,17-DODEC AHYDRO-CYCLOPENTA[A]PHENANTHREN-3-ONE / RU-486 / MIFEPRISTONE


Mass: 429.594 Da / Num. of mol.: 4 / Source method: obtained synthetically / Formula: C29H35NO2 / Comment: medication*YM
#4: Chemical ChemComp-GOL / GLYCEROL / GLYCERIN / PROPANE-1,2,3-TRIOL


Mass: 92.094 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: C3H8O3
#5: Water ChemComp-HOH / water


Mass: 18.015 Da / Num. of mol.: 27 / Source method: isolated from a natural source / Formula: H2O

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.97 Å3/Da / Density % sol: 58.64 %
Crystal growMethod: vapor diffusion, sitting drop / Details: VAPOR DIFFUSION, SITTING DROP

-
Data collection

DiffractionMean temperature: 100 K
Diffraction sourceSource: SYNCHROTRON / Site: SLS / Beamline: X10SA / Wavelength: 1 Å
DetectorType: MARMOSAIC 225 mm CCD / Detector: CCD / Date: Apr 19, 2007
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 1 Å / Relative weight: 1
ReflectionResolution: 2.8→43.1 Å / Num. obs: 36561 / % possible obs: 99.7 % / Redundancy: 5.24 % / Biso Wilson estimate: 70.2 Å2 / Rmerge(I) obs: 0.118 / Rsym value: 0.108 / Net I/σ(I): 11.7
Reflection shellResolution: 2.8→2.97 Å / Redundancy: 4.17 % / Rmerge(I) obs: 0.5 / Mean I/σ(I) obs: 2.9 / Num. unique all: 5762 / Rsym value: 0.612 / % possible all: 98.6

-
Processing

Software
NameVersionClassification
PHASERphasing
REFMAC5.5.0088refinement
XDSdata reduction
XSCALEdata scaling
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: PDB ENTRY 1M2Z
Resolution: 2.8→43.1 Å / Cor.coef. Fo:Fc: 0.933 / Cor.coef. Fo:Fc free: 0.889 / SU B: 38.888 / SU ML: 0.335 / TLS residual ADP flag: LIKELY RESIDUAL / Cross valid method: THROUGHOUT / ESU R: 1.104 / ESU R Free: 0.388 / Stereochemistry target values: MAXIMUM LIKELIHOOD / Details: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS
RfactorNum. reflection% reflectionSelection details
Rfree0.28317 1830 5 %RANDOM
Rwork0.22557 ---
obs0.22838 34667 99.84 %-
Solvent computationIon probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å / Solvent model: BABINET MODEL WITH MASK
Displacement parametersBiso mean: 39.184 Å2
Baniso -1Baniso -2Baniso -3
1--0.1 Å2-0.05 Å20 Å2
2---0.1 Å20 Å2
3---0.15 Å2
Refinement stepCycle: LAST / Resolution: 2.8→43.1 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms7828 0 134 27 7989
Refine LS restraints
Refine-IDTypeDev idealDev ideal targetNumber
X-RAY DIFFRACTIONr_bond_refined_d0.0090.0228128
X-RAY DIFFRACTIONr_bond_other_d0.0010.025378
X-RAY DIFFRACTIONr_angle_refined_deg1.131.99411019
X-RAY DIFFRACTIONr_angle_other_deg0.856313165
X-RAY DIFFRACTIONr_dihedral_angle_1_deg5.8665982
X-RAY DIFFRACTIONr_dihedral_angle_2_deg33.97924.103329
X-RAY DIFFRACTIONr_dihedral_angle_3_deg18.229151446
X-RAY DIFFRACTIONr_dihedral_angle_4_deg16.7131541
X-RAY DIFFRACTIONr_chiral_restr0.0590.21261
X-RAY DIFFRACTIONr_gen_planes_refined0.0040.028763
X-RAY DIFFRACTIONr_gen_planes_other0.0010.021570
X-RAY DIFFRACTIONr_nbd_refined
X-RAY DIFFRACTIONr_nbd_other
X-RAY DIFFRACTIONr_nbtor_refined
X-RAY DIFFRACTIONr_nbtor_other
X-RAY DIFFRACTIONr_xyhbond_nbd_refined
X-RAY DIFFRACTIONr_xyhbond_nbd_other
X-RAY DIFFRACTIONr_metal_ion_refined
X-RAY DIFFRACTIONr_metal_ion_other
X-RAY DIFFRACTIONr_symmetry_vdw_refined
X-RAY DIFFRACTIONr_symmetry_vdw_other
X-RAY DIFFRACTIONr_symmetry_hbond_refined
X-RAY DIFFRACTIONr_symmetry_hbond_other
X-RAY DIFFRACTIONr_symmetry_metal_ion_refined
X-RAY DIFFRACTIONr_symmetry_metal_ion_other
X-RAY DIFFRACTIONr_mcbond_it0.3811.54944
X-RAY DIFFRACTIONr_mcbond_other0.0451.51987
X-RAY DIFFRACTIONr_mcangle_it0.72127927
X-RAY DIFFRACTIONr_scbond_it0.87133184
X-RAY DIFFRACTIONr_scangle_it1.4634.53092
X-RAY DIFFRACTIONr_rigid_bond_restr
X-RAY DIFFRACTIONr_sphericity_free
X-RAY DIFFRACTIONr_sphericity_bonded
LS refinement shellResolution: 2.801→2.874 Å / Total num. of bins used: 20
RfactorNum. reflection% reflection
Rfree0.446 114 -
Rwork0.339 2494 -
obs--97.97 %
Refinement TLS params.

Method: refined / Refine-ID: X-RAY DIFFRACTION

IDL112)L122)L132)L222)L232)L332)S11 (Å °)S12 (Å °)S13 (Å °)S21 (Å °)S22 (Å °)S23 (Å °)S31 (Å °)S32 (Å °)S33 (Å °)T112)T122)T132)T222)T232)T332)Origin x (Å)Origin y (Å)Origin z (Å)
16.9628.2803-3.345810.3193-3.46452.4381-0.0860.2216-0.44690.02350.0343-0.71040.24-0.11080.05170.069-0.0362-0.0150.38880.05660.2287-34.08834.509-66.038
21.5051-0.84683.29621.8509-1.624710.48540.0550.0539-0.0133-0.22640.03710.00790.2241-0.1776-0.09210.1153-0.10560.09820.1916-0.01550.2439-45.11829.059-23.527
310.25672.2873-3.82730.7925-1.36672.45790.2192-0.2110.12170.1181-0.13120.0523-0.25630.1667-0.0880.2744-0.0931-0.00440.134-0.06740.2142-12.4945.26-6.773
42.0873-1.2818-0.55662.37310.02770.213-0.32290.27180.2565-0.01470.3705-0.18040.1535-0.1971-0.04760.3368-0.31860.09520.42630.01120.2681-53.51620.496-29.557
51.44960.23830.23312.0496-0.70192.0116-0.0620.2495-0.1608-0.20720.07940.0210.4098-0.0322-0.01740.3445-0.19230.10360.1557-0.08410.1386-44.8348.914-31.847
63.17010.9841-0.57511.5682-0.21151.1091-0.0148-0.0674-0.27830.1256-0.083-0.29880.12540.24170.09790.1878-0.08910.0010.13570.00250.2129-9.27130.427-6.054
72.7273-0.6731.25312.7305-0.34622.6976-0.131-0.21250.35820.04450.02710.4227-0.4048-0.69350.10390.2197-0.04260.05710.3428-0.03310.2991-55.56939.603-22.51
82.5281.71930.0354.5927-0.05081.85790.0592-0.02160.38240.19370.05450.3906-0.1854-0.3026-0.11370.02670.03870.02110.40110.0730.2016-43.64245.91-65.009
95.8585-2.61257.6312.965-5.524912.4806-0.35740.58550.7495-0.045-0.8519-0.6135-0.15821.47721.20930.53670.01370.02790.5269-0.03080.5275-35.90315.701-47.907
1011.12990.9873-0.72040.4077-1.03393.0137-0.27470.8137-0.7449-0.0232-0.0024-0.11950.05870.15130.27710.2745-0.01150.03790.1545-0.09460.268-21.63321.88-16.753
113.52131.8818-0.28181.5982-2.42479.6792-0.2596-0.14810.3321-0.1799-0.03590.1156-0.37940.25870.29550.4287-0.1387-0.01740.30680.0070.3845-41.96749.703-17.87
129.4517-2.46510.17930.6642-2.772411.8348-0.6626-0.25710.1977-0.01740.0528-0.11920.4183-0.86470.60981.6911-0.25650.64161.4197-0.18550.9278-48.5944.424-47.577
135.7667-3.4095.375612.1326-3.18315.0136-0.48130.95360.5035-0.73050.03050.0773-0.470.90020.45080.3206-0.22550.0710.28520.04310.2987-34.66525.577-36.517
144.0155-5.36966.88297.1899-9.206511.80020.29730.35290.0678-0.4582-0.3863-0.09070.50230.58950.08910.7121-0.60660.30270.7948-0.12640.6593-17.8434.237-23.566
Refinement TLS group
IDRefine-IDRefine TLS-IDAuth asym-IDAuth seq-ID
1X-RAY DIFFRACTION1A527 - 553
2X-RAY DIFFRACTION2B528 - 553
3X-RAY DIFFRACTION3C527 - 553
4X-RAY DIFFRACTION4D530 - 553
5X-RAY DIFFRACTION5A554 - 746
6X-RAY DIFFRACTION5A768 - 776
7X-RAY DIFFRACTION5A3
8X-RAY DIFFRACTION6B554 - 746
9X-RAY DIFFRACTION6B768 - 776
10X-RAY DIFFRACTION6B1
11X-RAY DIFFRACTION7C554 - 740
12X-RAY DIFFRACTION7C768 - 776
13X-RAY DIFFRACTION7C4
14X-RAY DIFFRACTION8D554 - 741
15X-RAY DIFFRACTION8D768 - 776
16X-RAY DIFFRACTION8D2
17X-RAY DIFFRACTION9A747 - 767
18X-RAY DIFFRACTION10B747 - 767
19X-RAY DIFFRACTION11C754 - 767
20X-RAY DIFFRACTION12D751 - 767
21X-RAY DIFFRACTION13N2260 - 2274
22X-RAY DIFFRACTION14M2265 - 2274

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbjlvh1.pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242):Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more